Oxycodone and Xanthogranuloma - a phase IV clinical study of FDA data
Summary:
We study 162,793 people who take Oxycodone (oxycodone hydrochloride) or have Xanthogranuloma. No report of Xanthogranuloma is found in people who take Oxycodone.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Oxycodone?
Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.
What is Xanthogranuloma?
Xanthogranuloma (self-limiting tumour with self healing) is found to be associated with 10 drugs and 97 conditions by eHealthMe. Check the latest studies of Xanthogranuloma.
No report is found.
Do you take Oxycodone and have Xanthogranuloma?
- Check whether Xanthogranuloma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Oxycodone:
- Oxycodone (162,592 reports)
Xanthogranuloma treatments and more:
- Xanthogranuloma (201 reports)
How severe was Xanthogranuloma and when was it recovered:
Expand to all the drugs that have ingredients of oxycodone hydrochloride:
Browse all side effects of Oxycodone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Xanthogranuloma:
Browse all the conditions that are associated with Xanthogranuloma:
How the study uses the data?
The study uses data from the FDA. It is based on oxycodone hydrochloride (the active ingredients of Oxycodone) and Oxycodone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Oxycodone and Sustiva - 7 seconds ago
- Drug interactions of Ribasphere and Lyrica - 9 seconds ago
- Drug interactions of Bactrim Ds and Erythromycin - 12 seconds ago
- Thrombosis and Back Pain Aggravated - 13 seconds ago
- Drug interactions of Adalat Cc and Actos - 14 seconds ago
- Drug interactions of Nuvigil and Actos - 14 seconds ago
- Could Ezetimibe cause Rhinitis? - 16 seconds ago
- Could Glucovance cause Hepatomegaly? - 17 seconds ago
- Could Calcitriol cause Indigestion? - 19 seconds ago
- Drug interactions of Oxaliplatin and Codeine - 23 seconds ago